We are live on ! Find out more
AP

AtonRa Partners Portfolio holdings

AUM $50.2M
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$26.5M
Cap. Flow
+$30.1M
Cap. Flow %
10.07%
Top 10 Hldgs %
22.19%
Holding
118
New
6
Increased
104
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
LSPD icon
Lightspeed Commerce
LSPD
+$5.25M
2
DSGX icon
Descartes Systems
DSGX
+$3.03M
3
LEGN icon
Legend Biotech
LEGN
+$1.39M
4
BRKR icon
Bruker
BRKR
+$1.25M
5
RKLB icon
Rocket Lab Corp
RKLB
+$1.2M

Top Sells

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$1.31M
2
BNTX icon
BioNTech
BNTX
+$1.14M
3
MNTS icon
Momentus
MNTS
+$928K
4
MCRB icon
Seres Therapeutics
MCRB
+$843K
5
ABT icon
Abbott
ABT
+$798K

Sector Composition

Rank Sector Weight
1 Technology 46.29%
2 Healthcare 31.99%
3 Financials 9.06%
4 Industrials 6.13%
5 Consumer Discretionary 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCT
101
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$936K 0.31%
21,156
+170
+0.8% +$7.69K
ADPT icon
102
Adaptive Biotechnologies
ADPT
$3.56B
$935K 0.31%
27,512
+1,263
+5% +$45.7K
NSTG
103
DELISTED
NanoString Technologies, Inc.
NSTG
$903K 0.3%
18,805
+8,128
+76% +$468K
BFLY icon
104
Butterfly Network
BFLY
$1.72B
$902K 0.3%
86,387
+11,591
+15% +$134K
FATE icon
105
Fate Therapeutics
FATE
$281M
$859K 0.29%
14,494
-8,717
-38% -$684K
BIIB icon
106
Biogen
BIIB
$29.9B
$825K 0.28%
2,914
+281
+11% +$92.1K
GWRE icon
107
Guidewire Software
GWRE
$11.5B
$735K 0.25%
6,185
+139
+2% +$16.1K
BNR
108
Burning Rock Biotech
BNR
$728K 0.24%
4,070
+526
+15% +$117K
EBS icon
109
Emergent Biosolutions
EBS
$375M
$727K 0.24%
14,519
+405
+3% +$24.5K
ASTR
110
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$625K 0.21%
+4,795
New +$733K
FSLY icon
111
Fastly Inc
FSLY
$3.17B
$541K 0.18%
13,375
+1,215
+10% +$56.1K
LU icon
112
Lufax Holding
LU
$1.2B
$509K 0.17%
18,244
+305
+2% +$10.1K
CELL
113
DELISTED
PhenomeX Inc. Common Stock
CELL
$403K 0.13%
20,600
+3,049
+17% +$116K
GOCO
114
DELISTED
GoHealth
GOCO
$384K 0.13%
5,096
+95
+2% +$10.1K
AMWL icon
115
American Well
AMWL
$181M
$311K 0.1%
1,708
+211
+14% +$45.8K
ACAD icon
116
Acadia Pharmaceuticals
ACAD
$4.25B
– –
-53,527
Closed -$1.31M
MCRB icon
117
Seres Therapeutics
MCRB
$48M
– –
-1,768
Closed -$843K
MNTS icon
118
Momentus
MNTS
$88.7M
– –
-5
Closed -$928K
1 2 3 4
5

Similar funds

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
SC
Sonen Capital San Francisco, California $52.7M AUM 25.58% 1-Year Est. Return
AOGP
Addition One General Partner New York $45.7M AUM
ACJ
Autonomy Capital (Jersey) St. Helier, Jersey $54.8M AUM 37.27% 1-Year Est. Return
UFG
United Fire Group Cedar Rapids, Iowa $55M AUM 6% 1-Year Est. Return
KC
Kellner Capital New York $55.5M AUM 88.05% 1-Year Est. Return
P
Pariax Newport Beach, California $44.3M AUM 12.57% 1-Year Est. Return
AMC
AKKR Management Company Menlo Park, California $42.5M AUM 123.1% 1-Year Est. Return

AtonRa Partners's Q3 2021 Portfolio in Review

As of Q3 2021, AtonRa Partners held 118 positions worth $299M, up 9.7% from $273M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AtonRa Partners deployed $30.1M of net new capital in Q3 2021, opening 6 new positions and adding to 104 existing holdings. Its largest new stake was Lightspeed Commerce: 52,877 shares worth $5.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 44% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was BioNTech, an estimated $1.14M trimmed.

  • AtonRa Partners's largest Q3 2021 buy was Lightspeed Commerce: 52,877 shares worth $5.1M.
  • AtonRa Partners added most to Pacific Biosciences in Q3 2021, an estimated $1.08M increase.
  • AtonRa Partners's biggest Q3 2021 reduction was BioNTech, cutting an estimated $1.14M.
  • AtonRa Partners fully exited Acadia Pharmaceuticals in Q3 2021, selling an estimated $1.31M.
  • AtonRa Partners's ten largest holdings make up 22% of its $299M portfolio in Q3 2021.
  • AtonRa Partners opened 6 new positions and closed 3 in Q3 2021.
  • AtonRa Partners's portfolio value rose 9.7% quarter-over-quarter to $299M.

Based on AtonRa Partners's 13F filing for Q3 2021, filed 15 Nov 2021.